ETFs With Bristol-Myers Squibb Company (BMY) Exposure
The following ETFs maintain significant exposure to Bristol-Myers Squibb Company (BMY); each of the following funds counts BMY among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|IHE||iShares U.S. Pharmaceuticals ETF||Health & Biotech Equities||0.46%||6.85%|
|PJP||Dynamic Pharmaceuticals||Health & Biotech Equities||0.63%||5.25%|
|PPH||Market Vectors Pharmaceutical ETF||Health & Biotech Equities||0.35%||4.70%|
|XPH||SPDR S&P Pharmaceuticals ETF||Health & Biotech Equities||0.35%||3.70%|
|XLV||Health Care Select Sector SPDR||Health & Biotech Equities||0.16%||3.62%|
|IYH||iShares U.S. Healthcare ETF||Health & Biotech Equities||0.46%||3.39%|
|FHLC||MSCI Health Care Index ETF||Health & Biotech Equities||0.12%||2.99%|
|VHT||Health Care ETF||Health & Biotech Equities||0.14%||2.85%|
|QINC||RBA Quality Income ETF||All Cap Equities||0.70%||2.14%|
|FVD||Value Line Dividend Index Fund||Large Cap Value Equities||0.70%||0.51%|
© 2014 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.